PREVENTion of Clot in Orthopaedic Trauma

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 12424 participants.

Also called NCT02984384

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 12,424 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02984384
Other papers using this trial's data
  • Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture The New England journal of medicine, 2023-01-19 DOI, PubMed 36652352

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02984384. Randomized; single masking; primary purpose prevention. Start 2017-04-24 (actual); primary completion 2022-02-18 (actual). Results posted on 2024-05-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PREVENTion of Clot in Orthopaedic Trauma
Acronym
PREVENT CLOT
Condition
Blood Clot
Condition
Trauma
Intervention (Drug)
Acetylsalicylic acid
Intervention (Drug)
Low Molecular Weight Heparin (LMWH)
Lead sponsor
Major Extremity Trauma Research Consortium (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct02984384
Content hash
0a7f5e53e4a3b6c12f5a69a36c7b76825f8f58930440169f1f87ce81d882af07